Waldencast plc WALD

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations Nasdaq

Last close 1.37 2026-09-04
Market cap $156.3M estimated share count
52-week range 0.72 - 3.22

Valuation FY2025 figures against the last close

P/S0.6x
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS-2.01

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue $272.1M$273.9M$218.1M$142.5M$94.4M
Cost of revenue $89.1M$82.1M$76.6M$55.0M$29.1M
Gross profit $183.0M$191.7M$141.6M$87.4M$65.3M
R&D $3.2M$6.1M$4.4M
SG&A $248.0M$245.3M$223.5M$83.0M$60.4M
Total operating expenses $400.6M$250.3M$223.5M$89.1M$64.8M
Operating income -$217.5M-$58.6M-$81.9M-$1.6M$528.0K
Interest expense $17.2M$18.9M$11.1M$6.3M
Pre-tax income -$262.2M-$48.5M-$112.9M-$10.0M-$5.8M
Income tax $14.2M$110.0K$7.0M$9.6M$3.4M
Net income -$229.7M-$42.4M-$90.0M-$19.6M-$2.4M
EPS, basic -2.01-0.39-0.99-2.45-0.30
EPS, diluted -2.01-0.39-0.99-2.45-0.30
Shares, diluted (wtd. avg.) $114.1M$109.3M$91.2M$8.0M$8.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents $30.4M$14.8M$21.1M$10.2M$13.4M$8.6M$3.4M
Receivables $18.7M
Inventory $54.6M$53.1M$55.7M$54.4M$21.6M
Total current assets $126.9M$103.6M$107.3M$91.0M$59.0M$166.8K
Property, plant and equipment $6.2M$5.8M$5.9M$8.3M$1.2M
Goodwill $0$329.6M$334.6M$334.6M$44.5M$44.5M
Other intangibles $427.1M$526.4M$582.9M$639.2M$79.6M
Total assets $746.2M$975.9M$1.04B$1.09B$184.6M$166.8K
Accounts payable $12.7M$177.7K
Short-term debt $771.0K$29.5M$8.5M$20.1M$15.4M
Total current liabilities $74.5M$76.9M$62.7M$72.5M$40.8M$177.7K
Long-term debt $135.8M$137.1M$151.3M$159.2M$103.4M
Total liabilities $246.1M$245.9M$273.4M$290.2M$145.3M$177.7K
Retained earnings -$519.0M-$289.2M-$246.8M-$156.8M-$64.8M-$11.0K
Total equity $461.9M$662.3M$769.3M$799.9M$39.2M-$11.0K

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating cash flow -$12.8M-$8.8M-$29.8M$3.5M-$7.4M
Depreciation and amortisation $3.1M$3.3M$3.8M$400.0K$0
Stock-based compensation $11.8M$9.4M$9.2M$0$0
Capital expenditure $3.4M$2.7M$1.6M$424.0K$1.1M
Investing cash flow $76.2M-$2.9M-$2.0M-$3.8M-$1.7M
Financing cash flow -$47.2M$5.6M$44.3M$5.2M$14.3M
Dividends paid $0$2.0M$2.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001840199-26-000019.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $70.77B 33.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $37.63B 207.7x 5.0%
KVUE Kenvue Inc. $36.00B 24.7x -2.1%
ELF e.l.f. Beauty, Inc. $6.47B 249.2x 24.6%
IPAR INTERPARFUMS INC $3.74B 22.3x 2.5%
COTY COTY INC. $2.58B -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.33B 54.5x -1.3%
SLSN SOLESENCE, INC. $60.0M 42.5x 18.6%